Background—We conducted a prospective longitudinal study to investigate the yet unknown
clinical significance of myocardial fibrosis in patients with non–ischemic cardiomyopathy …

Background—Late gadolinium enhancement-cardiac magnetic resonance is increasingly
performed in patients with systolic dysfunction. Numerous patterns of fibrosis are commonly …

Background: The prognosis of patients with idiopathic dilated cardiomyopathy (DCM) has
improved remarkably in recent decades with guideline-directed medical therapy. Left …

Objective Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) imaging
is the reference standard for non-invasive assessment of fibrosis. In hypertrophic …

Background The purpose of our study was to correlate the incidence of adequate
implantable cardioverter-defibrillator (ICD) interventions in hypertrophic cardiomyopathy …

Background—Fibrosis is a common end point of many pathological processes affecting the
myocardium and may alter myocardial relaxation properties. By measuring myocardial …

Background The presence of focal myocardial fibrosis, also called scar or replacement
fibrosis, detected with late gadolinium enhancement (LGE) cardiovascular magnetic …

Background: Myocardial fibrosis, identified by late gadolinium enhancement cardiovascular
magnetic resonance, predicts outcomes in chronic heart failure (HF). Its prognostic …

Background—In idiopathic dilated cardiomyopathy, there are scarce data on the influence of
late gadolinium enhancement (LGE) assessed by cardiovascular magnetic resonance on …

Cardiovascular magnetic resonance (CMR) with extensive late gadolinium enhancement
(LGE) is a novel marker for increased risk for sudden death (SD) in patients with …